Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paramananthan Mariappan

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
European Urology Oncology|October 11, 2025
Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer GroupRoger Li, Patrick J Hensley, Marko Babjuk, et al.
European Urology Oncology|May 14, 2026
Diagnostic Accuracy of Liquid-Based Biomarkers for Detecting and Risk Stratifying Upper Tract Urothelial Cancers: A Diagnostic Test Systematic Review by the EAU Guidelines UTUC PanelBhavan Prasad Rai, Karthik Rajan, Prabhakar Rajan, et al.
European Urology Oncology|May 12, 2026
Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPaolo Zaurito, Pietro Scilipoti, Alfonso Santangelo, et al.
European Urology Oncology|January 31, 2024
Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non-muscle-invasive Bladder CancerParamananthan Mariappan, Allan Johnston, Matthew Trail, et al.
European Urology|August 29, 2024
The Importance of Being Grade 3: A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non-muscle-invasive Bladder CancerIrene J Beijert, Oskar Hagberg, Truls Gårdmark, et al.
Health Technology Assessment (Winchester, England)|October 27, 2022
Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCTRakesh Heer, Rebecca Lewis, Anne Duncan, et al.
World Journal of Urology|August 16, 2018
ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancerLeonardo L Monteiro, J Alfred Witjes, Piyush K Agarwal, et al.
European Urology Oncology|January 29, 2025
A Systematic Review and Meta-analysis of the Clinical Impact of Prophylactic Quinolones with Adjuvant Bacillus Calmette-Guérin Instillation for Non-muscle-invasive Bladder CancerChris Ho-Ming Wong, Ivan Ching-Ho Ko, David Ka-Wai Leung, et al.
European Urology|August 25, 2024
Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient SelectionRoger Li, Patrick J Hensley, Shilpa Gupta, et al.
European Urology Oncology|June 21, 2024
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline PanelsLaura S Mertens, Harman Maxim Bruins, Roberto Contieri, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
European Urology Oncology|October 11, 2025
Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer GroupRoger Li, Patrick J Hensley, Marko Babjuk, et al.
European Urology Oncology|May 14, 2026
Diagnostic Accuracy of Liquid-Based Biomarkers for Detecting and Risk Stratifying Upper Tract Urothelial Cancers: A Diagnostic Test Systematic Review by the EAU Guidelines UTUC PanelBhavan Prasad Rai, Karthik Rajan, Prabhakar Rajan, et al.
European Urology Oncology|May 12, 2026
Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPaolo Zaurito, Pietro Scilipoti, Alfonso Santangelo, et al.
European Urology Oncology|January 31, 2024
Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non-muscle-invasive Bladder CancerParamananthan Mariappan, Allan Johnston, Matthew Trail, et al.
European Urology|August 29, 2024
The Importance of Being Grade 3: A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non-muscle-invasive Bladder CancerIrene J Beijert, Oskar Hagberg, Truls Gårdmark, et al.
Health Technology Assessment (Winchester, England)|October 27, 2022
Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCTRakesh Heer, Rebecca Lewis, Anne Duncan, et al.
World Journal of Urology|August 16, 2018
ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancerLeonardo L Monteiro, J Alfred Witjes, Piyush K Agarwal, et al.
European Urology Oncology|January 29, 2025
A Systematic Review and Meta-analysis of the Clinical Impact of Prophylactic Quinolones with Adjuvant Bacillus Calmette-Guérin Instillation for Non-muscle-invasive Bladder CancerChris Ho-Ming Wong, Ivan Ching-Ho Ko, David Ka-Wai Leung, et al.
European Urology|August 25, 2024
Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient SelectionRoger Li, Patrick J Hensley, Shilpa Gupta, et al.
European Urology Oncology|June 21, 2024
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline PanelsLaura S Mertens, Harman Maxim Bruins, Roberto Contieri, et al.
Pageof 7